mesalamine has been researched along with Cardiomyopathies in 1 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Cardiomyopathies: A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fleming, K | 1 |
| Ashcroft, A | 1 |
| Alexakis, C | 1 |
| Tzias, D | 1 |
| Groves, C | 1 |
| Poullis, A | 1 |
1 other study available for mesalamine and Cardiomyopathies
| Article | Year |
|---|---|
Proposed case of mesalazine-induced cardiomyopathy in severe ulcerative colitis.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Cardiomyopathies; Colitis, Ulcerative; Drug Substitu | 2015 |